News About: Pharm. Industry
Could TZD drugs regain lost market share?
Now all eyes are on the revival of thiazolidinediones (TZDs) as Duvier (lobeglitazone), one of TZDs to treat type 2 diabetes, obtained a green light from the Ministry of Food and Drug Safety on Thursday.
Another go...
Korea’s pharmaceutical market is valued at 19.2 trillion won in 2012
In Korea, considered one of Asia's top pharmaceutical markets, the total market size is valued at 19.22 trillion won, which is tantamount to almost 2 percent of the world’s pharmaceutical market, latest data showed We...
30 leading drugmaker’s production surpasses 57% in 2012 total output
Korea’s 30 leading drug firms have increased their output annually, with 57.1 percent in last year’s total drug production, figures showed Wednesday.
According to data disclosed by the Ministry of Food and Drug Saf...
Hanmi’s cephalosporin antibiotic gets EU GMP certification
Hanmi Pharm said Wednesday it acquired an EU GMP (Good Manufacturing Practice) certification for the manufacturing process of powder-form Triaxone (ceftriaxone) from the German health authorities on June 24.
The Ge...
Output of homegrown drugs tops 85.6 billion won in 2012
The combined output of Korea’s 14 new drugs posted 85.6 billion won last year, up 4 percent compared to 82.3 billion won (12 items) from a year earlier, statistics showed Wednesday.
Production records of Boryung Ph...
Multinational drug giants accused of low profit margins
Local drug wholesalers are finding it increasingly difficult to boost their bottom line amid falling profit margins and deteriorating transaction conditions with multinational drug manufactures.
Wholesalers saw the...
MFDS to add anaphylaxis to Pradaxa
The Ministry of Food and Drug Safety (MFDS) is considering adding a warning to the label of a blood thinner Pradaxa (dabigatran etexilate), to say the drug could cause anaphylaxis reactions.
Anaphylaxis is a seriou...
Chong Kun Dang chairman to step down
Chong Kun Dang Pharmaceutical Chairman Lee Jang-han will quit his co-president post at the company, officials said Tuesday.
However, Lee, the eldest son of the late founder Lee Chong-kun, is expected to retain its ...
Bayer Korea unveils new treatment for age-related macular degeneration
Bayer Korea said Tuesday it has started selling Eylea (aflibercept) injection for the treatment of patients with neovascular age-related macular degeneration.
Eylea is a recombinant fusion protein, consisting of po...
45 owners’ shares top 15.5%
The owners of 45 pharmaceutical firms listed on the bourse hold a 15.5 percent stake on average, a report said Monday.
According to the report released by Yakup.com, an online pharmaceutical information provider, t...
